Abstract
Breast cancer research benefits from a substantial collection of gene expression datasets that are commonly integrated to increase analytical power. Gene expression batch effects arising between experimental batches, where signal differences confound true biological variation, must be addressed when integrating datasets and several approaches exist to address these technical differences. This brief communication study clearly demonstrates that popular batch correction techniques can significantly distort key biomarker expression signals. Through the implementation of ComBat batch correction and evaluation of integrated expression values, we profile the extent of these distortions and consider an additional mitigatory batch correction step. We demonstrate that leveraging a priori knowledge of sample molecular subtype classification can optimally remove batch effect distortion while preserving key biomarker expression variation and transcriptional legitimacy. To the best of our knowledge, this study presents the first analysis of the interplay between dataset molecular composition and the concomitant robustness of integrated, batch-corrected biological expression signal.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No ethical approval was required. METABRIC sample gene expression data was obtained by requesting access from EGA:https://ega-archive.org/studies/EGAS00000000083.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
METABRIC datasets are available via committee approval. GSE6532 is freely available at https://www.ncbi.nlm.nih.gov/geo.
